Who Paid My Doc
DCRI Registry Study
Research payments
$5,465,899
Through program year 2025, $5,465,899 in research payments was reported against DCRI Registry Study, across 662 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..
- Paid by
- Boehringer Ingelheim Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $16,007 | 17 |
| 2024 | Research | $1,288,719 | 88 |
| 2023 | Research | $1,202,703 | 99 |
| 2022 | Research | $581,854 | 99 |
| 2021 | Research | $799,735 | 113 |
| 2020 | Research | $764,689 | 118 |
| 2019 | Research | $812,194 | 128 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kevin Flaherty Bend, OR Named on 15 payments
- Lisa Lancaster Hattiesburg, MS Named on 12 payments
- John Fitzgerald Dallas, TX Named on 12 payments
- Joseph Lasky New Orleans, LA Named on 11 payments
- Timothy Liesching Burlington, MA Named on 11 payments
- Timothy Whelan Charleston, SC Named on 10 payments
- Albert Baker Lynchburg, VA Named on 9 payments
- Domingo Chardon Ponce, PR Named on 9 payments
- Rajat Walia Phoenix, AZ Named on 9 payments
- David Hotchkin Portland, OR Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.